Download How Closely Should Cholesterol Be Monitored in Someone With an

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Medicine wikipedia, lookup

Patient safety wikipedia, lookup

Rhetoric of health and medicine wikipedia, lookup

Medical ethics wikipedia, lookup

Seven Countries Study wikipedia, lookup

Transcript
How Closely Should Cholesterol Be
Monitored in Someone With an MPN?
Olatoyosi Odenike, MD
Associate Professor of Medicine
University of Chicago Medical Center
Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors,
partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor.
That’s how you’ll get care that’s most appropriate for you.
Andrew Schorr:
Dr. Odenike, here's a question we got in from one of our listeners. Bonnie says, “How closely should cholesterol be
monitored for someone with an MPN? Do you recommend that all MPN patients be on a cholesterol-lowering medicine?”
Dr. Odenike:
Okay. I'll take the second part of the question first. So I do not recommend that all patients with MPNs be on a
cholesterol-lowering medicine. I do recommend, however, that, yes, patients with MPNs should have their cholesterol
monitored intermittently. I make that recommendation based on the fact that, first of all, many of us living in Western
countries tend to have high cholesterol. This can be influenced by diet, of course, and just in terms of good general medical
practice, health maintenance for individuals, particularly, you know, middle-aged and beyond it's a good thing to check
your cholesterol since that has an influence on heart disease. And for any disease, you know, having a healthy heart is
important to be able to tolerate medications, anything that your doctors may prescribe.
But beyond that we also know that in some MPNs, for example, you know, I will take primary myelofibrosis as an example,
some of the agents that we're using now to treat myelofibrosis, so ruxolitinib, popularly called Jakafi has been associated
with an increase in cholesterol levels. This can be a good thing initially if somebody who is losing weight and whose
cholesterol level naturally be lower, much lower than normal, which isn't a good thing either, when they get on Jakafi their
weight may improve and associated with that, you know, one can see a rise in cholesterol levels, so it is important to have
this checked periodically.
In terms of general medical practice, once a year or so is a reasonable interval to check cholesterol for the average person.
It may need to be checked more frequently depending on if a cholesterol-lowering medication is prescribed and that is
being monitored intermittently.
Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors,
partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor.
That’s how you’ll get care that’s most appropriate for you.